rs770991996

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1

The NM_000173.7(GP1BA):​c.1311_1349delAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCC​(p.Glu438_Pro450del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P437P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.79 ( 20002 hom., cov: 0)
Exomes 𝑓: 0.41 ( 110933 hom. )
Failed GnomAD Quality Control

Consequence

GP1BA
NM_000173.7 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 1.08

Publications

3 publications found
Variant links:
Genes affected
GP1BA (HGNC:4439): (glycoprotein Ib platelet subunit alpha) Glycoprotein Ib (GP Ib) is a platelet surface membrane glycoprotein composed of a heterodimer, an alpha chain and a beta chain, that is linked by disulfide bonds. The Gp Ib functions as a receptor for von Willebrand factor (VWF). The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and platelet glycoprotein V. The binding of the GP Ib-IX-V complex to VWF facilitates initial platelet adhesion to vascular subendothelium after vascular injury, and also initiates signaling events within the platelet that lead to enhanced platelet activation, thrombosis, and hemostasis. This gene encodes the alpha subunit. Mutations in this gene result in Bernard-Soulier syndromes and platelet-type von Willebrand disease. The coding region of this gene is known to contain a polymophic variable number tandem repeat (VNTR) domain that is associated with susceptibility to nonarteritic anterior ischemic optic neuropathy. [provided by RefSeq, Oct 2013]
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000173.7.
BP6
Variant 17-4933876-GGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCA-G is Benign according to our data. Variant chr17-4933876-GGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCA-G is described in ClinVar as Benign. ClinVar VariationId is 255466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.808 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000173.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GP1BA
NM_000173.7
MANE Select
c.1311_1349delAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCp.Glu438_Pro450del
disruptive_inframe_deletion
Exon 2 of 2NP_000164.5

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GP1BA
ENST00000329125.6
TSL:1 MANE Select
c.1311_1349delAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCp.Glu438_Pro450del
disruptive_inframe_deletion
Exon 2 of 2ENSP00000329380.5
CHRNE
ENST00000649830.1
c.-888+427_-888+465delTGGGGTGGTCGGGCTGGGGGCGGGCTCTGAGGTGGGCTC
intron
N/AENSP00000496907.1

Frequencies

GnomAD3 genomes
AF:
0.794
AC:
51619
AN:
65030
Hom.:
20005
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.800
Gnomad AMI
AF:
0.823
Gnomad AMR
AF:
0.787
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.600
Gnomad SAS
AF:
0.631
Gnomad FIN
AF:
0.741
Gnomad MID
AF:
0.754
Gnomad NFE
AF:
0.815
Gnomad OTH
AF:
0.783
GnomAD2 exomes
AF:
0.314
AC:
38907
AN:
123944
AF XY:
0.289
show subpopulations
Gnomad AFR exome
AF:
0.500
Gnomad AMR exome
AF:
0.448
Gnomad ASJ exome
AF:
0.176
Gnomad EAS exome
AF:
0.421
Gnomad FIN exome
AF:
0.230
Gnomad NFE exome
AF:
0.308
Gnomad OTH exome
AF:
0.381
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.413
AC:
317272
AN:
767336
Hom.:
110933
AF XY:
0.427
AC XY:
168203
AN XY:
393576
show subpopulations
African (AFR)
AF:
0.384
AC:
7665
AN:
19944
American (AMR)
AF:
0.440
AC:
12707
AN:
28894
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
9219
AN:
18770
East Asian (EAS)
AF:
0.552
AC:
12560
AN:
22764
South Asian (SAS)
AF:
0.417
AC:
23096
AN:
55436
European-Finnish (FIN)
AF:
0.638
AC:
23132
AN:
36260
Middle Eastern (MID)
AF:
0.476
AC:
1336
AN:
2808
European-Non Finnish (NFE)
AF:
0.384
AC:
209390
AN:
545924
Other (OTH)
AF:
0.497
AC:
18167
AN:
36536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
4718
9437
14155
18874
23592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.794
AC:
51618
AN:
65050
Hom.:
20002
Cov.:
0
AF XY:
0.786
AC XY:
23304
AN XY:
29644
show subpopulations
African (AFR)
AF:
0.798
AC:
10396
AN:
13022
American (AMR)
AF:
0.787
AC:
4541
AN:
5770
Ashkenazi Jewish (ASJ)
AF:
0.770
AC:
1418
AN:
1842
East Asian (EAS)
AF:
0.600
AC:
1150
AN:
1916
South Asian (SAS)
AF:
0.632
AC:
970
AN:
1536
European-Finnish (FIN)
AF:
0.741
AC:
2257
AN:
3046
Middle Eastern (MID)
AF:
0.750
AC:
81
AN:
108
European-Non Finnish (NFE)
AF:
0.815
AC:
29799
AN:
36546
Other (OTH)
AF:
0.780
AC:
624
AN:
800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
356
712
1067
1423
1779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.148
Hom.:
3

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 11, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jun 19, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GP1BA-related disorder Benign:1
Jan 28, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

CIC-rearranged sarcoma Other:1
Children's Cancer Therapy Development Institute
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=187/13
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770991996; hg19: chr17-4837171; COSMIC: COSV56701188; COSMIC: COSV56701188; API